BIONET Corp. (TPEX:1784)

BIONET Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,294	1,237	1,222	1,127	980.38	921.42
Revenue Growth	5.41%	1.19%	8.40%	14.99%	6.40%	14.24%
Gross Profit Gross Profit Growth	722.28	683.87	685.77	638.28	542.22	503.07
Operating Income Operating Income Growth	-15.81	-14.47	62.4	84.69	56.83	31.21
Net Income Net Income Growth	57.18	51.43	83.7	78.4	37.97	26.62
Earnings Per Share EPS Growth	1.14	1.02	1.65	1.55	0.75	0.52
EPS Growth	-18.64%	-38.23%	6.45%	107.50%	42.86%	108.83%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Stem Cells and Genetic Testing Products Stem Cells and Genetic Testing Products Growth	1,204	1,213	1,305	1,232	1,067	1,001
Write-Off Due to Consolidation Write-Off Due to Consolidation Growth	-223.86	-222.49	-325.44	-218.02	-184.3	-191.27
Other Departments Other Departments Growth	280.27	246.3	242.85	113.37	97.21	111.54
Total Total Growth	1,260	1,237	1,222	1,127	980.38	921.42

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,463	1,398	1,574	905.2	436.44	382.71
Total Debt Total Debt Growth	140.36	113.8	94.28	42.86	13.04	13.34
Net Cash (Debt) Net Cash Growth	1,322	1,285	1,480	862.33	423.4	369.37
Net Cash Growth	-8.32%	-13.21%	71.65%	103.67%	14.63%	-1.51%
Net Cash Per Share Net Cash Per Share Growth	26.29	25.41	29.12	17.02	8.34	7.24

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	169.12	148.04	176.49	153.1	94.65	13.88
Capital Expenditures CapEx Growth	-92.31	-123.62	-101.35	-20.04	-28.87	-10.17
Free Cash Flow Free Cash Flow Growth	76.81	24.42	75.15	133.05	65.78	3.71
Free Cash Flow Growth	26.47%	-67.51%	-43.52%	102.27%	1674.48%	-92.08%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	55.80%	55.30%	56.12%	56.62%	55.31%	54.60%
Operating Margin	-1.22%	-1.17%	5.11%	7.51%	5.80%	3.39%
Pretax Margin	1.66%	1.56%	8.37%	9.50%	7.19%	4.47%
Profit Margin	4.42%	4.16%	6.85%	6.96%	3.87%	2.89%
FCF Margin	5.93%	1.98%	6.15%	11.80%	6.71%	0.40%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.870	0.870	1.410	0.663	0.654	0.448
Dividend Per Share Growth	-37.80%	-38.30%	112.67%	1.44%	45.83%	166.63%
Dividend Yield	1.42%	0.84%	1.80%	1.25%	1.65%	1.27%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	52.40	101.25	48.18	34.92	54.33	70.61
Forward PE	-	235.01	235.01	235.01	235.01	235.01
P/FCF Ratio	39.10	213.22	53.66	20.58	31.36	507.15
PS Ratio	2.32	4.21	3.30	2.43	2.10	2.04

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error